Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-25-003718
Filing Date
2025-01-27
Accepted
2025-01-27 08:31:04
Documents
16

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm S-1/A 956927
2 ex4-35.htm EX-4.35 134935
3 ex4-36.htm EX-4.36 121042
4 ex4-37.htm EX-4.37 124637
5 ex10-51.htm EX-10.51 247740
6 ex10-52.htm EX-10.52 116267
7 ex23-1.htm EX-23.1 4647
8 ex107.htm EX-FILING FEES 33553
9 forms-1_001.jpg GRAPHIC 10276
10 forms-1_012.jpg GRAPHIC 96938
11 forms-1_003.jpg GRAPHIC 93095
12 forms-1_004.jpg GRAPHIC 20412
13 forms-1_005.jpg GRAPHIC 36185
14 forms-1_010.jpg GRAPHIC 53503
15 forms-1_011.jpg GRAPHIC 53393
16 forms-1_009.jpg GRAPHIC 12000
  Complete submission text file 0001493152-25-003718.txt   2259570
Mailing Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104
Business Address 315 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94104 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-284032 | Film No.: 25555832
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)